Pittsburgh -- U.S. scientists say they've created a new approach that has identified compounds with a potential for treating leishmaniasis -- a parasitic infection.
Medical scientists at the University of Pittsburgh and the Walter Reed Army Institute of Research screened nearly 200,000 chemical compounds and then regrouped them into chemotypes or chemical classes, both new and known, said senior investigator Professor John Lazo, director of the university's Drug Discovery Institute.
